Corrigendum to “Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants” [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]

Corrigendum to “Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants” [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]

Saved in:
Bibliographic Details
Published in:Journal of affective disorders Vol. 227; p. 198
Main Authors: Mischoulon, D., Hylek, L., Yeung, A.S., Clain, A.J., Baer, L., Cusin, C., Ionescu, D.F., Alpert, J.E., Soskin, D.P., Fava, M.
Format: Journal Article
Language:English
Published: Elsevier B.V 01-02-2018
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:erratum
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Correction/Retraction-1
ObjectType-Feature-3
content type line 23
ISSN:0165-0327
1573-2517
DOI:10.1016/j.jad.2017.10.040